Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia

por Lu, Xiaoxiao, Emond, Bruno, Morrison, Laura, Kinkead, Frederic, Lefebvre, Patrick, Lafeuille, Marie-Hélène, Khan, Wasiulla, Wu, Linda H, Qureshi, Zaina P, Jacobs, Ryan
Publicado 2023